Medical Devices
Technology
Health

Becton Dickinson

$246.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.39 (-0.56%) Today
-$1.39 (-0.56%) Today

Why Robinhood?

You can buy or sell BDX and other stocks, options, ETFs, and crypto commission-free!

About

Becton, Dickinson and Co., also called Becton Dickinson, is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. Read More The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Employees
76,032
Headquarters
Franklin Lakes, New Jersey
Founded
1897
Market Cap
66.61B
Price-Earnings Ratio
75.75
Dividend Yield
1.15
Average Volume
1.10M
High Today
$247.63
Low Today
$245.68
Open Price
$247.51
Volume
16.72K
52 Week High
$265.87
52 Week Low
$208.62

Collections

Medical Devices
Technology
Health
Medical
Healthcare
Pharmaceutical
Media
Cancer Prevention

News

MarketWatchMar 19

Becton Dickinson & Co.

Becton Dickinson & Co. said it expects to swing to fiscal first-quarter net earnings per share of $2.05, from a loss of 76 cents in the same period a year ago.

35
Simply Wall StMar 18

Should You Be Worried About Becton, Dickinson and Company’s (NYSE:BDX) 4.9% Return On Equity?

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we’ll use ROE to better understand Becton, Dickinson and Company (NYSE:BDX). Our data shows Becton Dickinson has a return on equity of 4.9% for the last year. One way to conceptualize this, is that for each $1 of shareholders’ equity it has, the company made $0.049 ...

19
Seeking AlphaMar 18

Becton Dickinson: Can This Stock Double Again?

With a diverse portfolio of medical devices, Becton Dickinson has positioned itself well for the coming boom. Today's post highlights another winner from an aging America. Regular readers have read my bull thesis on healthcare before. As baby boomers get older, they'll need more drugs, more testing, and more surgeries. This trend has created a boom for healthcare services and a growing stream of dividends for shareholders. You can see this bonanza reflected in the share prices for many companies like Merc...

101

Earnings

$2.37
$2.56
$2.74
$2.93
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected May 2, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.